Articles

Find an Article

Filter articles

Showing 1 to 10 of 741 results

Navigating the murky waters of the Hatch-Waxman ‘safe harbour’

US25-08-2022Jeanna Wacker and Tasha Francis Gerasimow

Safe harbour provisions can be relied on but their boundaries are still being defined, explain Jeanna Wacker and Tasha Francis Gerasimow of Kirkland & Ellis.

Microbial consortia: establishing a strong IP position in Europe

EU23-08-2022Ine Vanderleyden

Protecting new and inventive innovations in this increasingly crowded area is essential, explains Ine Vanderleyden of Mewburn Ellis.

The increasing relevance of ‘technical character’

EU16-08-2022Rosie McDowell

Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP.

CMA costs case improves access to justice

UK30-06-2022

The UK Supreme Court ruling involving Pfizer and Flynn is important for any company considering an appeal against the regulator, say Sophie Lawrance and James Batsford of Bristows.

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

23-06-2022Sarah Speight

The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight.

Gilenya injunction bid: big pharma takeaways

21-06-2022Azadeh Vahdat

The England and Wales Patent Court affirmed its power to grant injunctions for pre-grant patents—but not for Novartis, explains Azadeh Vahdat of EIP.

Why the ‘first penguin’ of pay for delay has not come in Japan: anatomy of a Japan paradox

Japan27-05-2022Takanori Abe

Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue.

Gene-editing bill: encouraging innovation or adding complexity?

UK26-05-2022Sarah Speight

UK legislation to streamline gene-editing technology research is promising for innovation, but presents potential complications for IP, finds Sarah Speight.

Neurim, Flynn discover that time is not on their side

UK26-05-2022Lydia Birch

The case reinforced the need for interim injunction applications to be made as quickly as possible, explains Lydia Birch of EIP.

South Africa: homeopathy case clarifies ‘medicine’ definition

South Africa23-05-2022Kareema Shaik and Jenny Pienaar

South Africa’s Supreme Court has declared regulations on complementary medicines invalid, explain Kareema Shaik and Jenny Pienaar of Adams & Adams.

Showing 1 to 10 of 741 results

LSIPR